Medication-related osteonecrosis of the jaw in osteoporotic patients: prevention and management

Inpatient cost for hip fracture patients managed with an orthogeriatric care model in Singapore

(2017) LT Tan et al.   SINGAPORE MEDICAL JOURNAL

Dental treatments, tooth extractions, and osteonecrosis of the jaw in Japanese patients with rheumatoid arthritis: results from the IORRA cohort study

(2016) Takefumi Furuya et al.   JOURNAL OF BONE AND MINERAL METABOLISM

Impact of the U.S. Food and Drug Administration's Safety-Related Announcements on the Use of Bisphosphonates After Hip Fracture

(2016) Seoyoung C Kim et al.   JOURNAL OF BONE AND MINERAL RESEARCH

Bisphosphonate drug holidays – when, why and for how long?

(2015) P. Anagnostis et al.   CLIMACTERIC

Osteonecrosis of the Jaw and Nonmalignant Disease: Is There an Association with Rheumatoid Arthritis?

(2013) G. Lescaille et al.   JOURNAL OF RHEUMATOLOGY

Secondary prevention of osteoporotic fractures—an “OPTIMAL” model of care from Singapore

(2013) M. Chandran et al.   OSTEOPOROSIS INTERNATIONAL

Impact of dental care in the prevention of bisphosphonate-associated osteonecrosis of the jaw: a single-center clinical experience

(2011) A. M. Vandone et al.   ANNALS OF ONCOLOGY

Bisphosphonate-induced osteonecrosis of the jaw: a review of 2,400 patient cases

(2010) O. Filleul et al.   JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY

Denosumab for Prevention of Fractures in Postmenopausal Women with Osteoporosis

(2009) Steven R. Cummings et al.   NEW ENGLAND JOURNAL OF MEDICINE

Reduction of osteonecrosis of the jaw (ONJ) after implementation of preventive measures in patients with multiple myeloma treated with zoledronic acid

(2008) M. A. Dimopoulos et al.   ANNALS OF ONCOLOGY